BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

681 related articles for article (PubMed ID: 26794876)

  • 21. pH-sensitive and folic acid-targeted MPEG-PHIS/FA-PEG-VE mixed micelles for the delivery of PTX-VE and their antitumor activity.
    Di Y; Li T; Zhu Z; Chen F; Jia L; Liu W; Gai X; Wang Y; Pan W; Yang X
    Int J Nanomedicine; 2017; 12():5863-5877. PubMed ID: 28860753
    [TBL] [Abstract][Full Text] [Related]  

  • 22. pH-Responsive Poly(Ethylene Glycol)-block-Polylactide Micelles for Tumor-Targeted Drug Delivery.
    Xiao L; Huang L; Moingeon F; Gauthier M; Yang G
    Biomacromolecules; 2017 Sep; 18(9):2711-2722. PubMed ID: 28774173
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oligo(lactic acid)n-Paclitaxel Prodrugs for Poly(ethylene glycol)-block-poly(lactic acid) Micelles: Loading, Release, and Backbiting Conversion for Anticancer Activity.
    Tam YT; Gao J; Kwon GS
    J Am Chem Soc; 2016 Jul; 138(28):8674-7. PubMed ID: 27374999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Encapsulating paclitaxel in polymeric nanomicelles increases antitumor activity and prevents peripheral neuropathy.
    Oda CMR; Silva JO; Fernandes RS; Braga AV; Machado RR; Coelho MM; Cassali GD; Reis DC; de Barros ALB; Leite EA
    Biomed Pharmacother; 2020 Dec; 132():110864. PubMed ID: 33254426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paclitaxel delivered by CD44 receptor-targeting and endosomal pH sensitive dual functionalized hyaluronic acid micelles for multidrug resistance reversion.
    Liu Y; Zhou C; Wei S; Yang T; Lan Y; Cao A; Yang J; Hou Y
    Colloids Surf B Biointerfaces; 2018 Oct; 170():330-340. PubMed ID: 29936386
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An injectable thermosensitive hydrogel self-supported by nanoparticles of PEGylated amino-modified PCL for enhanced local tumor chemotherapy.
    Guo J; Feng Z; Liu X; Wang C; Huang P; Zhang J; Deng L; Wang W; Dong A
    Soft Matter; 2020 Jun; 16(24):5750-5758. PubMed ID: 32529197
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel biocompatible intraperitoneal drug delivery system increases tolerability and therapeutic efficacy of paclitaxel in a human ovarian cancer xenograft model.
    Vassileva V; Grant J; De Souza R; Allen C; Piquette-Miller M
    Cancer Chemother Pharmacol; 2007 Nov; 60(6):907-14. PubMed ID: 17375303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation.
    Danhier F; Lecouturier N; Vroman B; Jérôme C; Marchand-Brynaert J; Feron O; Préat V
    J Control Release; 2009 Jan; 133(1):11-7. PubMed ID: 18950666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and evaluation of novel tumor-targeting paclitaxel-loaded nano-carriers for ovarian cancer treatment: in vitro and in vivo.
    Yao S; Li L; Su XT; Wang K; Lu ZJ; Yuan CZ; Feng JB; Yan S; Kong BH; Song K
    J Exp Clin Cancer Res; 2018 Feb; 37(1):29. PubMed ID: 29478415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor-Targeting Micelles Based on Linear-Dendritic PEG-PTX
    Zhang Y; Lu Y; Zhang Y; He X; Chen Q; Liu L; Chen X; Ruan C; Sun T; Jiang C
    Mol Pharm; 2017 Oct; 14(10):3409-3421. PubMed ID: 28832164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics and biodistribution of polymeric micelles of paclitaxel with Pluronic P123.
    Han LM; Guo J; Zhang LJ; Wang QS; Fang XL
    Acta Pharmacol Sin; 2006 Jun; 27(6):747-53. PubMed ID: 16723095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paclitaxel prodrugs with sustained release and high solubility in poly(ethylene glycol)-b-poly(epsilon-caprolactone) micelle nanocarriers: pharmacokinetic disposition, tolerability, and cytotoxicity.
    Forrest ML; Yáñez JA; Remsberg CM; Ohgami Y; Kwon GS; Davies NM
    Pharm Res; 2008 Jan; 25(1):194-206. PubMed ID: 17912488
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Difunctional Pluronic copolymer micelles for paclitaxel delivery: synergistic effect of folate-mediated targeting and Pluronic-mediated overcoming multidrug resistance in tumor cell lines.
    Wang Y; Yu L; Han L; Sha X; Fang X
    Int J Pharm; 2007 Jun; 337(1-2):63-73. PubMed ID: 17289311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Self-assembled micelles based on N-octyl-N'-phthalyl-O-phosphoryl chitosan derivative as an effective oral carrier of paclitaxel.
    Qu G; Hou S; Qu D; Tian C; Zhu J; Xue L; Ju C; Zhang C
    Carbohydr Polym; 2019 Mar; 207():428-439. PubMed ID: 30600025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complete Regression of Xenograft Tumors upon Targeted Delivery of Paclitaxel via Π-Π Stacking Stabilized Polymeric Micelles.
    Shi Y; van der Meel R; Theek B; Oude Blenke E; Pieters EH; Fens MH; Ehling J; Schiffelers RM; Storm G; van Nostrum CF; Lammers T; Hennink WE
    ACS Nano; 2015; 9(4):3740-52. PubMed ID: 25831471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paclitaxel and curcumin coadministration in novel cationic PEGylated niosomal formulations exhibit enhanced synergistic antitumor efficacy.
    Alemi A; Zavar Reza J; Haghiralsadat F; Zarei Jaliani H; Haghi Karamallah M; Hosseini SA; Haghi Karamallah S
    J Nanobiotechnology; 2018 Mar; 16(1):28. PubMed ID: 29571289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dual Receptor-Targeted and Redox-Sensitive Polymeric Micelles Self-Assembled from a Folic Acid-Hyaluronic Acid-SS-Vitamin E Succinate Polymer for Precise Cancer Therapy.
    Yang Y; Li Y; Chen K; Zhang L; Qiao S; Tan G; Chen F; Pan W
    Int J Nanomedicine; 2020; 15():2885-2902. PubMed ID: 32425522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Engineering folate-targeting diselenide-containing triblock copolymer as a redox-responsive shell-sheddable micelle for antitumor therapy in vivo.
    Behroozi F; Abdkhodaie MJ; Abandansari HS; Satarian L; Molazem M; Al-Jamal KT; Baharvand H
    Acta Biomater; 2018 Aug; 76():239-256. PubMed ID: 29928995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. α-Tocopherol Succinate-Anchored PEGylated Poly(amidoamine) Dendrimer for the Delivery of Paclitaxel: Assessment of in Vitro and in Vivo Therapeutic Efficacy.
    Bhatt H; Kiran Rompicharla SV; Ghosh B; Biswas S
    Mol Pharm; 2019 Apr; 16(4):1541-1554. PubMed ID: 30817166
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved Core Viscosity Achieved by PDLLA
    Guo C; Zhang Y; Yuan H; Zhang Y; Yin T; He H; Gou J; Tang X
    Pharm Res; 2022 Feb; 39(2):369-379. PubMed ID: 35118566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.